文献速递中医内科中药与中成药合理使用

中药对心肌缺血再灌注损伤影响的研究进展综述

Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review.
PubMed 文献 · Front Pharmacol · 2022-12-06

该综述通过电子检索文献、专利和民族药理学资料,系统汇总中药活性成分、复方抗心肌缺血再灌注损伤(MIRI)的药效与机制研究,指出中药多成分多靶点优势可弥补单成分药物不足,为临床用药提供科学支持并揭示发展前景。

要点

  • 中药多成分多靶点特性在抗MIRI中较单成分药物具明显优势。
  • 综述汇总中药活性成分与复方抗MIRI的药效及潜在机制研究。
  • 系统数据挖掘有助于加速抗MIRI药物发现与协同组方筛选。

核心结论

  • 中药多成分多靶点作用为其抗MIRI提供显著优势,可克服单成分药物不足,为MIRI治疗指向新途径。

研究设计与样本

  • 综述类研究,通过电子检索文章、专利和民族药理学文档,系统挖掘中药抗MIRI相关数据。

主要发现

  • 综述报告了中药活性成分、中药复方抗MIRI的药效及潜在机制研究进展。
  • 中药多靶点效应被视为抗MIRI的显著优势,可弥补单成分药物缺点。

临床怎么用

  • 综述为中药治疗MIRI的临床使用提供科学支持,并揭示相应临床意义与发展前景。
  • 系统数据挖掘有助于加速药物发现进程并识别安全候选药物与协同组方。

局限性

  • 原文指出目前总结中药抗MIRI的综述非常少,本综述旨在填补该汇总空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ischemic heart disease (IHD) is a high-risk disease in the middle-aged and elderly population. The ischemic heart may be further damaged after reperfusion therapy with percutaneous coronary intervention (PCI) and other methods, namely, myocardial ischemia-reperfusion injury (MIRI), which further affects revascularization and hinders patient rehabilitation. Therefore, the investigation of new therapies against MIRI has drawn great global attention. Within the long history of the prevention and treatment of MIRI, traditional Chinese medicine (TCM) has increasingly been recognized by the scientific community for its multi-component and multi-target effects. These multi-target effects provide a conspicuous advantage to the anti-MIRI of TCM to overcome the shortcomings of single-component drugs, thereby pointing toward a novel avenue for the treatment of MIRI. However, very few reviews have summarized the currently available anti-MIRI of TCM. Therefore, a systematic data mining of TCM for protecting against MIRI will certainly accelerate the processes of drug discovery and help to identify safe candidates with synergistic formulations. The present review aims to describe TCM-based research in MIRI treatment through electronic retrieval of articles, patents, and ethnopharmacology documents. This review reported the progress of research on the active ingredients, efficacy, and underlying mechanism of anti-MIRI in TCM and TCM formulas, provided scientific support to the clinical use of TCM in the treatment of MIRI, and revealed the corresponding clinical significance and development prospects of TCM in treating MIRI.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Xing N, Long XT, Zhang HJ, et al. Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review. Front Pharmacol. 2022. PMID: 36561346. doi:10.3389/fphar.2022.1055248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。